Renal and vascular injury induced by exogenous angiotensin II is AT1 receptor-dependent

Nephron

Volumn 87, Issue 1, 2001, Pages 66-74

  Lombardi, Donna M ^a   Viswanathan, Mohan ^b   Vio, Carlos P ^c   Saavedra, Juan M ^b   Schwartz, Stephen M ^a   Johnson, Richard J ^d,e  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

ACE inhibitor; Angiotensin II; Ballooned carotid; Kidney; Losartan

Indexed keywords

ALPHA ACTIN; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; COLLAGEN TYPE 3; COLLAGEN TYPE 4; DESMIN; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOSARTAN; OSTEOPONTIN; RAMIPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL INJURY; CAROTID ARTERY; CONTROLLED STUDY; DRUG RECEPTOR BINDING; HYPERTENSION; KIDNEY INJURY; MALE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEINURIA; RAT; RECEPTOR BLOCKING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIHYPERTENSIVE AGENTS; BALLOON DILATATION; BLOOD PRESSURE; BODY WEIGHT; CAROTID ARTERY INJURIES; KIDNEY DISEASES; LOSARTAN; MALE; PEPTIDYL-DIPEPTIDASE A; RAMIPRIL; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; VASOCONSTRICTOR AGENTS;

EID: 0035101453     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000045886     Document Type: Article

References (45)

1. Angiotensin II-mediated renal injury
2. Renal injury from angiotensin II-mediated hypertension
3. Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis
4. Receptor mediated intrarenal angiotensin II augmentation in angiotensin II-infused rats
5. Production of hypertension and vascular disease by angiotensin
6. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall
7. Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism
8. Prevention of angiotensin II induced myocyte necrosis and coronary vascular damage by lisinopril and losartan in the rat
9. The intrarenal renin-angiotensin system: A paracrine system for the local control of renal function separate from the systemic axis
10. Pressure and angiotensin II synergistically induce aortic fibronectin expression in organ culture model of rabbit aorta. Evidence of a pressure-induced tissue renin angiotensin system
11. Augmentation of intrarenal angiotensin II levels by chronic angiotensin II infusion
12. Renal accumulation of circulating angiontensin II in angiotensin II-infused rats
13. Cellular expression of angiotensin type-1 receptor mRNA in the kidney
14. In vitro autoradiography reveals predominantly AT1 angiotensin II receptors in rat kidney
15. Localization and functional properties of angiotensin II AT1 receptors in the kidney: Focus on renomedullary interstitial cells
16. Balloon angioplasty enhances the expression of angiotensin II AT1 receptors in neointima of rat aorta
17. Angiotensin II-induced progression of neointimal thickening in the balloon-injured rat carotid artery is AT1 receptor mediated
18. Presence of angiotensin II AT2 receptor binding sites in the adventitia of human kidney vasculature
19. Upregulation of renin-angiotensin system during differentiation of monocytes to macrophages
20. Synthesis and effects of active fragments of angiotensin II
21. Up-regulation of AT4 receptor levels in carotid arteries following balloon injury
22. Angio-tensin(1-7) reduces smooth muscle growth after vascular injury
23. Endothelial regeneration. V. Inhibition of endothelial regrowth in arteries of rat and rabbit
24. Examination of the urine
25. Expression and characterization of recombinant angiotensin I-converting enzyme. Evidence for a C-terminal transmembrane anchor and for a proteolytic processing of the secreted recombinant and plasma enzymes
26. Increased angiotensin I-converting enzyme in epithelial, endothelial and interstitial cells in hypertensive kidneys
27. Glomerular angiotensin II receptor subtypes during development of rat kidney
28. Angiotensin-converting enzyme in non-neoplastic kidney diseases
29. Regulation of type 1 angiotensin II receptor and its subtype gene expression in kidney by sodium loading and angiotensin II infusion
30. Regulation of angiotensin II type 1 receptor mRNA and protein in angiotensin II-induced hypertension
31. Differential regulation of renal glomerular and preglomerular vascular angiotensin II receptors
32. Angiotensin II receptor type I gene expression in human glomerulonephritis and diabetes mellitus
33. Angiotensin II upregulates type-1 angiotensin II receptors in renal proximal tubule
34. Hemodynamic theory of progressive renal disease: A 10-year update in brief review
35. Regulation of papillary plasma flow by angiotensin II
36. Progressive renal disease: The chronic hypoxia hypothesis
37. Experimental insights into the tubulointerstitial disease accompanying primary glomerular lesions
38. 5-angiotensin II-infused rats is mediated by AT1 receptor
39. Regulation of proximal tubular osteopontin in experimental hydronephrosis in the rat
40. Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor beta
41. Angiotensin II-stimulated nitric oxide release from porcine pulmonary endothelium is mediated by angiotensin IV
42. Novel angiotensin peptides regulate blood pressure, endothelial function, and natriuresis
43. The renin-angiotensin system and ramipril, a new converting enzyme inhibitor
44. The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy
45. Randomized placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and the risk of terminal renal failure in proteinuric, non-diabetic nephropathy